Tremeau is a Massachusetts-based pharmaceutical company focused on providing non-opioid pain treatments for well-defined patient populations with significant unmet needs.
Tremeau’s unique approach to acute and chronic pain in select conditions is rooted in the mechanism of action, documented efficacy, and clinically differentiated profile of COX-2 selective NSAIDs.
Company Details
- Founded
- -
- Address
- 53 Main St.,
- In****@****uRx.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- tremeaurx.com
- Keywords
- Vedanta Biosciences.
- HQ
- Concord, MA
Tremeau Pharmaceuticals, Inc. Questions
Tremeau Pharmaceuticals, Inc.'s website is tremeaurx.com
Tremeau Pharmaceuticals, Inc.'s LinkedIn profile is https://www.linkedin.com/company/tremeau-pharmaceuticals
Tremeau Pharmaceuticals, Inc.'s industry is
Pharmaceutical Manufacturing
Tremeau Pharmaceuticals, Inc.'s top competitors are
Tevard Biosciences,
Vedanta Biosciences, Inc.,
Idrx,
Aviva Bio,
Silver Creek Pharmaceuticals,
Ceretype Neuromedicine, Inc.,
Gurnet Point Capital,
D9 Designs Inc.,
Walden Biosciences,
Lennham Pharmaceuticals.
Tremeau Pharmaceuticals, Inc.'s support email address is Info@TremeauRx.com
Tremeau Pharmaceuticals, Inc.'s categories are Pharmaceutical Manufacturing
Tremeau Pharmaceuticals, Inc.'s founding year is 2016
